Cssc Science & Technology Co.Ltd(600072) intends to issue shares to acquire new energy industry assets and resume trading on the 13th; Sichuan Hebang Biotechnology Co.Ltd(603077) and others are expected to double their performance in 2021; Shandong Fengyuan Chemical Co.Ltd(002805) it is proposed to raise no more than 940 million yuan for the lithium iron phosphate cathode material production base project of lithium battery; Andon Health Co.Ltd(002432) : the U.S. subsidiary has signed a large sales order
today’s highlights
▼ focus one:
Cssc Science & Technology Co.Ltd(600072) intends to issue shares to acquire assets in the new energy industry and resume trading on the 13th
The company plans to purchase 100% shares of China shipping, 10% minority equity of lingjiu electric, 44.64% minority equity of Luoyang Shuangrui, 88.58% equity of CSSC wind power and 100% equity of Xinjiang Haiwei by issuing shares. Meanwhile, the company plans to raise supporting funds. The issue price of issuing shares to purchase assets is determined as 12.50 yuan / share.
This transaction constitutes a major asset restructuring. After the completion of the transaction, the listed company will directly hold 100% shares of China haizhuang and 100% shares of Xinjiang Haiwei, and will jointly hold 100% shares of lingjiu electric, 100% shares of Luoyang Shuangrui and 100% shares of China Shipbuilding wind power through direct and indirect means. The target assets of this restructuring are new energy industry assets, mainly engaged in the manufacturing of wind power generation equipment, the development and operation of wind farms and photovoltaic power stations, new energy engineering construction services, etc. The trading of the company’s shares will resume from the opening of the market on January 13, 2022.
▼ focus II:
Sichuan Hebang Biotechnology Co.Ltd(603077) and others are expected to double their performance in 2021
Sichuan Hebang Biotechnology Co.Ltd(603077) : disclosure of performance forecast. The company expects to realize the net profit attributable to the shareholders of the listed company in 2021, which will increase by 29590575-3259057500 yuan compared with the same period of the previous year, with a year-on-year increase of 7227.36% – 7960.09%.
Shanghai Huayi Group Corporation Limited(600623) : disclosure of performance forecast. The company expects to realize the net profit attributable to the shareholders of the listed company in 2021, which will increase by 2376560000 yuan to 2776560000 yuan compared with the same period of the previous year, with a year-on-year increase of 561% to 656%.
Petrochina Company Limited(601857) : disclosure of performance forecast. The company expects to realize the net profit attributable to the shareholders of the company in 2021, which will increase by 71 billion yuan to 75 billion yuan, an increase of 374% to 395% compared with the same period of the previous year; Compared with the same period in 2019, it will increase by 44.3 billion yuan to 48.3 billion yuan, an increase of 97% to 106%, and an average increase of 40% to 43% in two years, the best level in the same period in recent seven years.
Tangshan Sunfar Silicon Industry Co.Ltd(603938) : disclosure of performance forecast. The net profit attributable to the shareholders of the listed company in 2021 is expected to be 326 million yuan to 345 million yuan, an increase of 234.85% to 254.36% year-on-year.
Wuxi Shangji Automation Co.Ltd(603185) : disclosure of performance forecast. The company expects that the net profit attributable to the shareholders of the listed company in 2021 will be RMB 163 million to RMB 180 million, with a year-on-year increase of 207% to 239%.
Sichuan Yahua Industrial Group Co.Ltd(002497) : disclosure of performance forecast. The company expects to make a profit of 92-105 million yuan in 2021, an increase of 184.09% – 224.23% over the same period of last year.
Teyi Pharmaceutical Group Co.Ltd(002728) : disclosure of performance forecast. The company expects to make a profit of 120 million yuan to 150 million yuan in 2021, an increase of 173.87% – 242.34% over the same period of last year.
Jiangsu Cnano Technology Co.Ltd(688116) : disclosure of performance forecast. The company expects that the net profit attributable to the owners of the parent company in 2021 will be 285 million yuan to 305 million yuan, with a year-on-year increase of 165.73% to 184.38%.
Snowsky Salt Industry Group Co.Ltd(600929) : disclosure of performance forecast. The company’s net profit attributable to shareholders of Listed Companies in 2021 is expected to increase by 234.65 million yuan to 284.65 million yuan compared with the same period of last year, with a year-on-year increase of 161% to 196%.
Shan Dong Lubei Chemcal Co.Ltd(600727) : disclosure of performance forecast. The company expects to realize the net profit attributable to the shareholders of the listed company in 2021, which will increase by about 270.35 million yuan compared with the same period of the previous year, with a year-on-year increase of about 117%.
Yinbang Clad Material Co.Ltd(300337) : disclosure of performance forecast. The company expects to make a profit of 35-45 million yuan in 2021, an increase of 106.33% – 165.28% over the same period of last year.
Anhui Truchum Advanced Materials And Technology Co.Ltd(002171) : disclosure of performance forecast. The company expects to make a profit of 550-600 million yuan in 2021, an increase of 100.55% – 118.78% over the same period of last year.
▼ focus III:
Andon Health Co.Ltd(002432) : the U.S. subsidiary signs major contracts for daily operation and obtains orders
The U.S. subsidiary of the company and the Department of health of New York state signed the sales contract on January 10, 2022 local time to sell ihealth kit products to the Department of health of New York state; The U.S. subsidiary received the purchase order for ihealth kit from the Department of health of New York State on December 21, 2021 local time; The U.S. subsidiary obtained the purchase order from the Executive Office of the federal and Department of health and human services of Massachusetts from December 3, 2021 to January 5, 2022 local time. The U.S. subsidiary sold ihealth kits to the Executive Office of the federal and Department of health and human services of Massachusetts.
The cumulative amount of orders and contracts between the U.S. subsidiary and the Department of health of New York is 185310000.00 U.S. dollars (about 1179646400.00 yuan), and the cumulative amount of orders with the Executive Office of the Federal Department of health and human services of Massachusetts is 148327400.00 U.S. dollars (about 944222562.92 yuan). The performance of orders and contracts will have a positive impact on the company’s operating revenue and operating profit in 2021 and 2022.
performance selection
Beijing Sanju Environmental Protection & New Materials Co.Ltd(300072) : disclosure of performance forecast. The company expects to make a profit of 69 million yuan to 103 million yuan in 2021, with a loss of 1380160500 yuan in the same period of last year.
Anhui Genuine New Materials Co.Ltd(603429) : disclosure of performance forecast. The company expects the net profit attributable to the shareholders of the listed company in 2021 to be about 136 million yuan, an increase of about 89.47% year-on-year.
Zhejiang Jingsheng Mechanical & Electrical Co.Ltd(300316) : disclosure of performance forecast. The company expects to make a profit of 158 million yuan to 184 million yuan in 2021, an increase of 84.11% – 114.41% over the same period of last year.
Xinjiang Communications Construction Group Co.Ltd(002941) : disclosure of performance forecast.
The company expects to make a profit of 185-277 million yuan in 2021, an increase of 61.34% – 141.58% over the same period of last year.
Shanghai Qifan Cable Co.Ltd(605222) : disclosure of performance forecast. The company expects to achieve a net profit attributable to shareholders of listed companies of RMB 651 million to RMB 708 million in 2021, with a year-on-year increase of 58.78% to 72.68%.
Xiamen Xiangyu Co.Ltd(600057) : disclosure of performance forecast. The company expects the net profit attributable to shareholders of Listed Companies in 2021 to be RMB 1.96 billion-2.210 billion, with a year-on-year increase of 51% – 70%.
Hangzhou Tigermed Consulting Co.Ltd(300347) : disclosure of performance forecast. The company expects to make a profit of RMB 2624662200-3027110400 in 2021, an increase of 50% – 73% over the same period of last year.
Zhejiangtailin Bioengineering Co.Ltd(300813) : disclosure of performance forecast. The company expects to make a profit of 58.07 million yuan to 72.58 million yuan in 2021, an increase of 20.02% – 50% over the same period of last year.
Citic Securities Company Limited(600030) : release performance express. In 2021, the company achieved an operating revenue of 76.57 billion yuan, a year-on-year increase of 40.80%; The net profit attributable to the shareholders of the parent company was 22.979 billion yuan, a year-on-year increase of 54.20%.
Suli Co.Ltd(603585) : release performance express. In 2021, the company realized an operating revenue of 2284019200 yuan, a year-on-year increase of 46.54%; The net profit attributable to shareholders of the listed company was 226440400 yuan, a year-on-year increase of 29.58%.
fixed increase & restructuring
Shandong Fengyuan Chemical Co.Ltd(002805) : disclose the plan for non-public offering of shares. The objects of this issuance are no more than 35 specific objects, including Zhao Guanghui, the controlling shareholder and actual controller of the company, and the total amount of funds raised is no more than 940 million yuan. After deducting the issuance expenses, it will be used for “production base project of lithium iron phosphate cathode material for lithium battery with an annual output of 50000 tons” and “supplementary working capital project”.
Suzhou Medicalsystem Technology Co.Ltd(603990) : the company recently received a notice from Mr. Weng Kang, the controlling shareholder of the company, and Yan huanghong and Wang Jianhua, who acted in concert. They are planning to change the controlling shareholder and actual controller of the company. The trading of the company’s shares has been suspended since the opening of the market on January 13, 2022, and the suspension is expected to be no more than two trading days.
important
Jiangsu Eastern Shenghong Co.Ltd(000301) : Guowang high tech fiber (Suqian) Co., Ltd., a secondary wholly-owned subsidiary of the company, will invest in the construction of phase II super simulated functional fiber project with an annual output of 500000 tons. The total investment of the project is expected to be 3.612 billion yuan and the construction period is 2 years; Jiangsu Ruibang Technology Co., Ltd., a secondary wholly-owned subsidiary of the company, will invest in the construction of phase II project with an annual output of 250000 tons of recycled differentiated and functional polyester filament and supporting texturing. The total investment of the project is expected to be 2.838 billion yuan and the construction period is 2 years.
Fujian Acetron New Materials Co.Ltd(300706) : dingchuang metal, a wholly-owned subsidiary of the company, recently signed an investment letter of intent with the people’s Government of Shaxian District, Sanming City. Dingchuang metal plans to invest in new vanadium alloy and other new material production projects in Shaxian District, Sanming City. The project plans to invest 250 million yuan, including 150 million yuan in fixed assets, mainly engaged in the R & D, production and sales of new materials such as vanadium alloy.
Hualan Biological Engineering Inc(002007) : according to the reply on Approving the registration of initial public offering of Hualan Biological Engineering Inc(002007) vaccine Co., Ltd. issued by the CSRC on January 12, 2022, the CSRC agrees to the registration application of Hualan vaccine, the holding subsidiary of the company, for initial public offering of shares on the gem. Hualan vaccine will carry out follow-up work in accordance with the relevant regulations and requirements of China Securities Regulatory Commission and Shenzhen Stock Exchange.
Andon Health Co.Ltd(002432) : according to the announcement on the disclosure of abnormal stock trading fluctuations and risk tips, the company previously submitted the proposal on using family self-test box to realize Omicron covid-19 epidemic prevention 1 + 1 to Tianjin epidemic prevention and control headquarters. At present, relevant departments are studying the proposal, and it is uncertain whether the proposal will be adopted.
Fuchun Technology Co.Ltd(300299) : on January 12, 2022, the company received a notice from the controlling shareholder Fujian Fuchun Investment Co., Ltd., the actual controller Miao pinzhang, and the President Chen Ping (hereinafter referred to as the “relevant party”), who received the notice of filing a case from the CSRC. Due to suspected securities violations, In accordance with the securities law of the people’s Republic of China, the administrative punishment law of the people’s Republic of China and other laws and regulations, the CSRC decided to file a case. According to the company’s preliminary understanding, this case filing is a special investigation on the reduction of the company’s shares or non-compliance of related parties in block transactions at the end of 2020. This matter does not involve the company’s financial fraud, capital occupation, illegal guarantee and other situations, has nothing to do with the listed company, and will not have an impact on the daily business activities of the company and its subsidiaries.
Ikd Co.Ltd(600933) : the company plans to issue convertible bonds to the public, raising no more than 1.6 billion yuan. After deducting the issuance expenses, all of them will be used for the project of Ikd Co.Ltd(600933) Intelligent Manufacturing Technology Industrial Park.
Sichuan Furong Technology Co.Ltd(603327) : the company plans to sign a formal investment agreement with Luoyuan county government and Fuzhou Taiwan Investment Zone Management Committee to build a high-precision electronic consumption and high-end manufacturing base of new materials in Luoyuan County, Fuzhou City, Fujian Province. It is planned to purchase 942.3 mu of land at one time and build it by stages. The investment amount is 5 billion yuan (including working capital, including fixed asset investment of 3 billion yuan), of which the investment in phase I project is expected to be 1.218 billion yuan. After the investment project is fully completed, the company will increase the production capacity of consumer electronics aluminum, which will help the company solve the problem of insufficient production capacity in peak season, further improve the market share of products and maintain the company’s leading market position.
Zhe Jiang Li Zi Yuan Food Co.Ltd(605337) : Yunnan Zhe Jiang Li Zi Yuan Food Co.Ltd(605337) Food Co., Ltd., a wholly-owned subsidiary, plans to invest in the construction of three aseptic filling production lines for milk containing beverages, supporting the construction of warehouses and other ancillary facilities. The total land scale of the project is about 89 mu, and the total planned investment is about 200 million yuan.
Beijing-Shanghai High Speed Railway Co.Ltd(601816) : the company signed a strategic cooperation agreement with China electric power on January 11. The two sides will establish a long-term strategic cooperation relationship and carry out strong alliance in power market trading, comprehensive intelligent energy investment, construction and operation, green and low-carbon energy supply, so as to realize resource sharing and complementary advantages and jointly promote the extension and development of business of both sides.
Henan Zhongfu Industrial Co.Ltd(600595) : the trading of the company’s shares will be suspended for one day from the opening of the market on January 13, 2022 and resumed from the opening of the market on January 14, 2022. Since the opening of the company’s stock market on January 14, 2022, the delisting risk warning has been revoked and other risk warnings continue to be implemented. The stock abbreviation has been changed from ” Henan Zhongfu Industrial Co.Ltd(600595) ” to “St Zhongfu”, and the stock code remains unchanged.
increase / decrease
Aier Eye Hospital Group Co.Ltd(300015) : on January 12, 2022, Li Li, vice chairman and general manager of the company, increased 300000 shares of the company through the securities trading system of Shenzhen Stock Exchange, accounting for 0.0055% of the total share capital of the company; Subsequently, it is proposed to increase the company’s shares by no less than 5000000 shares (excluding 300000 shares already increased) within 6 months after the announcement date, and the increase price shall not be higher than 50 yuan / share.
Guoanda Co.Ltd(300902) : Hong Weiyi, the controlling shareholder, one of the actual controllers, chairman and general manager of the company, recently increased his holdings of 142000 shares of the company through secondary market transactions, accounting for 0.11% of the total share capital of the company. The increase price range is 39.00 yuan / share – 42.86 yuan / share, and the increase amount is 5.5723 million yuan. Hong Weiyi plans to increase his holdings of the company’s shares through centralized bidding, block trading or other means permitted by laws and regulations within 6 months from January 10, 2022. The total amount of capital to increase his holdings of shares is not less than 10 million yuan and not more than 20 million yuan (including 5.5723 million yuan that has been increased recently).
Intco Medical Technology Co.Ltd(300677) : the company received the letter of commitment on not reducing Intco Medical Technology Co.Ltd(300677) shares signed by Liu Fangyi, the controlling shareholder and actual controller of the company, on January 12, 2022. Liu Fangyi made a voluntary commitment: from the date of issuance of the letter of commitment to June 30, 2023, he will not reduce any shares of Intco Medical Technology Co.Ltd(300677) held by him through centralized bidding, block trading and agreement transfer (including the shares increased due to Intco Medical Technology Co.Ltd(300677) share distribution, capital reserve conversion to share capital and other reasons during the commitment period).
Kunming Longjin Pharmaceutical Co.Ltd(002750) : Lixing Industrial Co., Ltd., a shareholder holding 80582343 shares of the company (accounting for 20.12% of the total share capital of the company), plans to reduce its shares by centralized bidding, block trading or other legal means to no more than 24030000 shares (accounting for 6% of the total share capital of the company) within 6 months.
Jiangsu Chuanzhiboke Education Technology Co.Ltd(003032) : Shanghai chuangji Investment Center (limited partnership), the shareholder holding 21730182 shares of the company (accounting for 5.40% of the total share capital of the company), plans to reduce the total shares of the company by means of centralized bidding and block trading within six months (accounting for 2.70% of the total share capital of the company).
Changjiangrunfa Health Industry Co.Ltd(002435) : Zhongshan Songde Zhangjiagang Free Trade Zone pharmaceutical industry equity investment enterprise (limited partnership), a shareholder holding 144067797 shares of the company (accounting for 11.66% of the total share capital of the company), plans to reduce the company’s shares by no more than 24711457 shares (accounting for 2% of the total share capital of the company) within six months after 15 trading days from the announcement date.
Hengtong Logistic Co.Ltd(603223) : on January 12, 2022, Nanshan investment, the concerted action of Nanshan Group, the controlling shareholder of the company, increased 228300 shares of the company, accounting for 0.08% of the total share capital of the company. Nanshan investment plans to increase its shares in the company at an appropriate price within three months from January 12, 2022. The amount of shares to be increased shall not be less than 30 million yuan and not more than 60 million yuan (including the amount of shares increased this time).
Skshu Paint Co.Ltd(603737) : after the closing on January 12, 2022, the company’s phase V ESOP has purchased 12947757 shares of the company’s shares through block trading and secondary market purchase, accounting for 3.44% of the company’s total share capital, with a transaction amount of 1922482997.46 yuan and an average transaction price of about 148.48 yuan / share. The company has completed the purchase of the subject shares of the company’s fifth employee stock ownership plan within 6 months after the deliberation and approval of the company’s general meeting of shareholders.
Jinko Power Technology Co.Ltd(601778) : Bihua venture capital, a shareholder with a shareholding of 9.35%, intends to reduce the number of shares of the company by means of centralized bidding transaction by no more than 57882900 shares within no more than 6 months after 15 trading days from the date of disclosure of this announcement, and the reduction proportion shall not exceed 2% of the total share capital of the company.
summary of suspension and resumption
resumption company:
\u3000\u3000 Cssc Science & Technology Co.Ltd(600072) (600072)。
Suspended company:
\u3000\u3000 Henan Zhongfu Industrial Co.Ltd(600595) (600595)、 Suzhou Medicalsystem Technology Co.Ltd(603990) (603990)。
